Sos and colleagues have shown that the presence of mutated or amplified receptor tyrosine kinase in non-small cell lung cancer cell lines correlated with increased sensitivity and apoptosis following treatment with PI3K inhibitors [137]. This evidence concerns the gene PIK3CA and non-small cell lung carcinoma.